Default company panoramic image
82a48da4 a352 424f ba48 c146ed240bd9

EVA Corporation

EVA is focused on the design and fabrication of devices for use in the endovascular treatment of abdominal aortic aneurysms (AAAs)

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Bethesda, MD, US
  • Currency USD
  • Founded September 1996
  • Employees 3

Company Summary

The Company is seeking to raise funds to complete and commercialize its staple technology for preventing migration of AAA grafts and expanding its technology into use with a specially designed revolutionary surgical device that treats AAAs in a minimally invasive manner that is safer, more effective, more durable, and less costly than other commercially available treatment options.

Team

  • Default avatar
    Tom Walsh
    Chief Executive Officer

    Mr. Walsh serves as chief executive officer of the company. He is president, Walsh financial services and senior vice president Mesirow financial structured settlements. He was president of the New York Stock Exchange member firm and a founder and initial investor in DC Venture Capital Corp., Balance Bar Incorporated (went public and was subsequently sold to Kraft Foods) and Marietta Corporation (became a public company - since purchased by a

  • Default avatar
    Hugh Trout
    Chief Medical Officer, Founder

    Dr. Trout currently serves as Clinical Professor of Surgery at George Washington University Medical Center and at the Uniformed Services University of Health Sciences. He served on the national Vascular Joint Council as Treasurer of the Society for Vascular Surgery from 1997 to 2002. He also served as a Consultant in Vascular Surgery at the National Cancer Institute of the National Institutes of Health and at the Veterans Administration Hospita

  • Default avatar
    Ken Spector
    Vice President, Research & Development

    Mr. Spector has over thirty years of design and management experience in the medical device industry, ranging from product conception through commercialization. He is experienced in multidisciplined technical team development and management that is required for development of high quality diagnostic and therapeutic devices.

Advisors

  • Default avatar
    John M. Bryan Bean, Kinney & Korman Arlington, VA
    Lawyer
    Unconfirmed
    Default avatar
    Mcglladrey Raleigh, NC
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Friends and family round
    Unconfirmed
    Default avatar
    $7.7 million raise
    Unconfirmed